Friday, 5 December 2014

Public Health Department is recommending more than $7 million in grant money for eight studies centered on research into both the safety of medical cannabis

Colorado state’s Public Health Department is recommending more than $7 million in grant money for eight studies centered on research into both the safety of cannabis and the possibilities for its use as a treatment for symptoms of various ailments and diseases.

Some of the research seems to be based around promising earlier work done outside the United States. A 2004 survey at the Prague Movement Disorder Center indicated that more that half of Parkinson’s Disease patients who tried cannabis noticed subjective improvement. Israeli researchers in 2013 presented an observational study of 17 Parkinson’s patients that showed a 30 percent increase in their average Parkinson’s Disease Rating Scale. So “A Randomized, Double-blind, Placebocontrolled Crossover Study of Tolerability and Efficacy of Cannabidiol (CBD) on Tremor in Parkinson’s Disease” sounds really promising in finding out whether those results were subjective or not.

 http://www.whereismydoctor.com/images/news/67c3954e158477ef8932558379059e7d.jpg
Medical cannabis - So bring on the research. Bring on the studies. But for goodness sakes, lay off the hyperbole.

Another, “Cannabidiol (CBD) and Pediatric Epilepsy,” might share some insight into why CBD, one of the most active cannabinoids, eases symptoms of certain forms of epilepsy in children. This is a subject of interest to a growing number of Americans, especially after the Sanjay Gupta CNN medical marijuana documentaries last year and work done by Israeli scientists. Subjective evidence indicates there is definitely something happening, enough so that parents are moving to Colorado to gain access to a particular CBD strain. A scientific study might shed light on why it’s happening.

Some research has suggested a connection between the endocannabinoid system and how the brain processes traumatic memories. So “Treating PTSD with Marijuana: Clinical and Functional Outcomes” and “A Double Blind, Placebo-Controlled Cross Study Comparing the Analgesic Efficacy of Cannabis versus Oxycodone” aim right at the heart of a serious debate about whether cannabis might be effective in treating symptoms of post traumatic stress syndrome in our veterans, who are sometimes treated with narcotic drugs, which puts them at risk for opioid abuse and other side effects.

Read More: http://www.boulderweekly.com/article-13740-finally-some-cannabi.html

No comments:

Post a Comment